Tutorial in biostatistics: competing risks and multi-state models.
about
How to handle mortality when investigating length of hospital stay and time to clinical stabilityThe VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular diseaseOutcomes of localized prostate cancer following conservative managementRegression methods for investigating risk factors of chronic kidney disease outcomes: the state of the artThreats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survivalRadiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 YearsThe effect of adherence to statin therapy on cardiovascular mortality: quantification of unmeasured bias using falsification end-pointsDouble-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple SclerosisUsing electronic health records to predict costs and outcomes in stable coronary artery diseaseSex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort studyLifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and nutrition (EPIC) studyElevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deathsSurvival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatmentAddressing the Heterogeneity of Heart Failure in Future Randomized Trials.Survival Analysis in the Presence of Competing Risks: The Example of Waitlisted Kidney Transplant Candidates.Breast cancer risk is increased in the years following false-positive breast cancer screeningTime-dependent endpoints as predictors of overall survival in multiple myelomaEffect of an event occurring over time and confounded by health status: estimation and interpretation. A study based on survival data simulations with application on breast cancer.Statistical analysis of life history calendar data.Suitability for subcutaneous defibrillator implantation: results based on data from routine clinical practice.Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data.Matching methods to create paired survival data based on an exposure occurring over time: a simulation study with application to breast cancer.Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial.Estimation of Drug Effectiveness by Modeling Three Time-dependent Covariates: An Application to Data on Cardioprotective Medications in the Chronic Dialysis Population.Biodemographic Analyses of Longitudinal Data on Aging, Health, and Longevity: Recent Advances and Future Perspectives.Contralateral breast cancer risk in relation to tumor morphology and age-in which patients is preoperative MRI justified?Bayesian path specific frailty models for multi-state survival data with applications.Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis.Bayesian Semi-parametric Analysis of Semi-competing Risks Data: Investigating Hospital Readmission after a Pancreatic Cancer Diagnosis.Multivariate meta-analysis using individual participant data.A comparative study of prevalence-based incidence estimation techniques with application to dementia data in Germany.An ensemble survival model for estimating relative residual longevity following stroke: Application to mortality data in the chronic dialysis populationUnderstanding competing risks: a simulation point of viewSevere morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009.Introduction to the Analysis of Survival Data in the Presence of Competing RisksSemi-Competing Risks Data Analysis: Accounting for Death as a Competing Risk When the Outcome of Interest Is NonterminalThe Role of Influenza in the Delay between Low Temperature and Ischemic Heart Disease: Evidence from Simulation and Mortality Data from JapanSafety data from randomized controlled trials: applying models for recurrent events.Nonparametric estimation in the illness-death model using prevalent data.Accounting for measurement error in biomarker data and misclassification of subtypes in the analysis of tumor data
P2860
Q23913313-DD9364B1-D312-4919-86F0-BB6E70CFE2B8Q24613094-ECB78A10-DDE0-4F0C-BFF0-6A7A069FD185Q24647380-8118B0E9-2FF0-45D9-9D6F-34701E31047DQ26827335-059F184B-1AE1-4E1B-9F57-A20F4C4CF931Q27022747-9BD1B3F9-4603-494E-93D8-876B65C65F93Q28264598-41A364F8-CAAC-4A37-A6E3-42921977FAA4Q28391835-0FC779F9-3572-451B-935D-A07AA95A2EC6Q28584487-0319531F-6058-45C6-B97A-9AD8DF173D43Q28603610-D00534B9-8F8C-4380-8C68-8D7C90C2853EQ28652095-BAAB070D-C307-4C13-B00F-59C153771394Q28655880-CDB531BF-7F16-487B-9CB2-46719F2272DCQ28741566-EE768C0B-38F4-4D7E-9881-4F16730DC1C3Q28750627-3F4BDB59-90BC-4993-9166-4A83EFCFEDADQ30234708-DAD5E683-D4EE-4ABC-8EA5-DC6F7DE2B1F8Q30251974-620D981A-3A79-4C2B-8B5A-B9216C9646AEQ30490199-5B851343-7EA6-4553-B9D2-55889DA3E4ABQ30538040-804078F0-27F4-464B-B9D9-21B8794168ACQ30570485-8BDF8C5B-6644-4F56-A177-56B9C704BFFAQ30575664-E3139018-6C10-4070-9053-45B5A62E41AFQ30632380-2E671481-19E1-4FE0-BE5B-CB0BE3A738EEQ30675919-B2DD1C20-8A8D-49A2-9980-BA9981315387Q30833393-0450925E-0021-4B3C-9B41-D74A4C152CCBQ30840447-A0A7951B-19BC-487D-84D7-0A5A98CC8A68Q30863924-3362B9CF-B912-4069-8952-FFE4F5E8683AQ30884486-CF313D3C-C77F-4BCB-BFB5-892DA19EA80BQ30891857-BB3A82F9-4C7B-425C-A7DD-C85146CA88C3Q30908752-6B0E55CA-C1DD-4C5D-9907-12CF7521F380Q30927999-E23302CA-5C6D-4218-B4EF-65268CACDAE6Q30952198-9417E562-AFE6-4518-929C-D35155028742Q30976009-62D32EF8-5E87-4EFD-9ABC-048E62117395Q30993876-08D90B31-B13A-47D6-9EE0-4B7013BB970CQ30996974-22BB9077-8631-4CC5-B740-6BC46068C07EQ31015561-3C5AEA13-B400-46DF-A1D5-36AD17E715DFQ31020587-C25B36E9-C577-4C87-9003-7E125F4941D3Q31043722-06C9D26D-67AC-4BA3-83AE-0D556A88AF4AQ31075577-DE9DAB8A-B7DB-46D7-9133-57C621856C10Q31089234-79C0F627-A17A-4157-AA6B-B6CFE8303C35Q31107512-C4A1C686-354A-4364-88D1-9C29C8771E45Q31111135-050E038B-FDB8-4E30-B35E-E82DF78B900FQ31123458-5399987F-8292-4EF1-85A9-B1005233528B
P2860
Tutorial in biostatistics: competing risks and multi-state models.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tutorial in biostatistics: competing risks and multi-state models.
@ast
Tutorial in biostatistics: competing risks and multi-state models.
@en
type
label
Tutorial in biostatistics: competing risks and multi-state models.
@ast
Tutorial in biostatistics: competing risks and multi-state models.
@en
prefLabel
Tutorial in biostatistics: competing risks and multi-state models.
@ast
Tutorial in biostatistics: competing risks and multi-state models.
@en
P2093
P356
P1476
Tutorial in biostatistics: competing risks and multi-state models.
@en
P2093
P304
P356
10.1002/SIM.2712
P407
P577
2007-05-01T00:00:00Z